11，Bramwell VHC. The role ofchemotherapy in the management of non-metastatic operable extremity osteosarcoma[J].Semi in Oncol, 1997；24(5):561～571
22，Picci P,Ferrari S,Bacci G et al. Treatment recommendation for osteosarcoma and softtissue sarcoma[J].Drug,1994；47(1):82～92
33，Meyers PA， Gorlick R. Osteosarcoma[J]. Pediatr Oncol, 1997；44(4):973～989
44，Picci P, Sangiorgi BT, Neff JR et al. Relationship of chemotherapy-induced necrosisand surgical margins to local recurrence in osteosarcoma[J]. J Clin Oncol, 1994；12(12):2699～2 705
55，Bacci G,Picci P,Ruggieri P et al. Primary chemotherapy and delayed surgery(neoadjuvant chemotherapy) for osteosarcoma of the extremities：the rizzolisexperience in 127 patients treated preoperatively with methotrexate iv (high vs moderatedose) and cisplatinum ia[J].Cancer,1990；65(11):2 539～2 553
66，Blaney SM, Smith MA, Grem JL. Doxorubicin:Role in the treatment of osteosarcoma[A].In:HumphreyGB, Koops HS,Molenaar WM et al eds.Osteosacoma in adolescents and young adults:newdevelopments and controversies[M].Boston:Kluwer Academic Pub,1993：55～73
77，Antman KH, Growley J, Balcerzak SP et al.An intergroup phase Ⅲ randomized study ofdoxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft-tissueand bone sarcoma[J]. J Clin Oncol,1993；11(6):1 276～1 285
88，Uchida A,Myoui A,Araki N et al. Neoadjuvant chemotherapy for pediatric osteosarcomapatients[J]. Cancer, 1997；79(2):411～415
99，Rosen G.An opinion supporting the role of high-dose methotrexate in the treatment ofosteosarcoma[A].In:Humphrey GB, Koops HS, Molenaar WM et al eds.Osteosacoma inAdolescents and Young Adults:New Developments and Controversies[M].Boston:KluwerAcademic Pub,1993：49～54
1010，Salch RA, Graham-Pole J, Cassano WF et al. Response of osteogenic sarcoma to thecombination of etoposide and cyclophosphamide as neoaduvant chemo-therapy[J]. Cancer,1990;65(4):861～865
6Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy [ J ]. Cancer, 2002,49 (6) : 1221-1230.
7Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity [ J ]. N Engl J Med, 2005,314 (25) : 1600- 1606.
8Jaffe N. Recent advances in the chemotherapy of metas tatic osteogenic sarcoma [ J]. Clin Orthop Relat Res, 2000, (270) :4-7.
9Marina N, Gebhardt M,Teot L, et al. Biology and therapeutic advances for pediatric osteo-sarcoma [J]. Oncologist,2004,9 (4):422-441.
10Bielack SS,Machatschek JN, Flege S, et al. Delaying surgery with chemotherapy for osteo-sarcoma of the extremities[ J ]. Expert Opin Pharmacother, 2004,5 ( 6 ) : 1243- 1256.
